Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability of Telmisartan and Dipyridamole Co-administration
NCT02262793Phase 1Completed
- Sponsor
- Boehringer Ingelheim
- Start
- May 2004
- Primary completion
- Jul 2004
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of telmisartan and dipyridamole in hypertension (HTN) and stroke (4 arms), sponsored by Boehringer Ingelheim. Primary endpoints: Area under the concentration-time curve in plasma from 0 extrapolated to infinity up to 72 hours and Maximum concentration in plasma up to 72 hours. Started May 2004; status: completed.
02
Drugs
telmisartandipyridamole
03
Conditions
hypertension (HTN)stroke
Beyond the preview
Go deeper on NCT02262793.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02262793.